July 2, 2024
TOPLINE: Long-term, supervised exercise therapy significantly improves the functional ability and quality of life in patients with axial spondyloarthritis (axSpA) and severe functional limitations. METHODOLOGY: This […]
July 2, 2024
AMSTERDAM — Nurses need to be fully involved in developing the tools that are meant to make workflows within the healthcare system more efficient, delegates at […]
July 2, 2024
The European Medicines Agency (EMA), through the Pharmacovigilance Risk Assessment Committee (PRAC), has concluded that therapy with CAR-T cells may be directly linked to the onset […]
July 2, 2024
Only a quarter of the estimated 4% of American adults who needed medication for opioid use disorder (MOUD) in 2022 received the treatment, according to a […]
July 2, 2024
TOPLINE: Robust multidisciplinary support is crucial for encouraging internal medicine residents to pursue primary care careers, as many are deterred by administrative burdens and concerns about […]
July 2, 2024
New research supports current guidelines cautioning against long-term use of benzodiazepines. The study of more than 5000 older adults found that benzodiazepine use was associated with […]
July 1, 2024
The US Food and Drug Administration (FDA) has approved ustekinumab-ttwe (Pyzchiva) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. In addition, […]
July 1, 2024
Delivery Method: UPS Overnight Product: DrugsFood & Beverages Recipient: Recipient Name Tommy W. Kerzee Recipient Title Owner Lone Star Botanicals Inc. 2001 Broussard St.Tyler, TX 75701-8406United […]
July 1, 2024
Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of […]